Evidence map›Paper›PMID 27995961›Full record

ArticleScientific reports2016

Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay.

Maywan Hariono, Nurshariza Abdullah, K V Damodaran, Ezatul E Kamarulzaman, Nornisah Mohamed, Sharifah Syed Hassan, Shaharum Shamsuddin, Habibah A Wahab

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. The therapeutic potential ofFrontiers in pharmacology · 2026
    Review
  4. Article
  5. Foods (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Toxicology reports · 2024
    Article
  8. Review
  9. Article
  10. Phenolic Compounds inMolecules (Basel, Switzerland) · 2023
    Review
  11. Review
  12. Article
  13. PhytoestrogenVaccines · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maywan HarionoSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia.
Nurshariza AbdullahSchool of Health Sciences, Universiti Sains Malaysia, 16150 Kubang Krian, Kelantan, Malaysia.
K V DamodaranSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia.
Ezatul E KamarulzamanSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia.
Nornisah MohamedSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia.
Sharifah Syed HassanJeffry Cheah School of Medicine and Health Sciences, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Islam, Malaysia.
Shaharum ShamsuddinSchool of Health Sciences, Universiti Sains Malaysia, 16150 Kubang Krian, Kelantan, Malaysia.
Habibah A WahabSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Pulau Pinang, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the computational and experimental efforts in the design and synthesis of novel neuraminidase (NA) inhibitors from ferulic acid and vanillin. Two proposed ferulic acid analogues, MY7 and MY8 were predicted to inhibit H1N1 NA using molecular docking. From these two analogues, we designed, synthesised and evaluated the biological activities of a series of ferulic acid and vanillin derivatives. The enzymatic H1N1 NA inhibition assay showed MY21 (a vanillin derivative) has the lowest IC

Indexed as

Biological AssayModels, MolecularAntiviral AgentsBenzaldehydesBinding SitesCoumaric AcidsCrystallography, X-RayEnzyme InhibitorsInfluenza A Virus, H1N1 SubtypeInhibitory Concentration 50Molecular Docking SimulationNeuraminidaseAntiviral AgentsBenzaldehydesCoumaric AcidsEnzyme Inhibitorsferulic acidNeuraminidasevanillin

Identifiers

PMID27995961
PMCPMC5171792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.